189 related articles for article (PubMed ID: 11431171)
1. Comparison of twice- and three times daily tiagabine for the adjunctive treatment of partial seizures in refractory patients with epilepsy: an open label, randomised, parallel-group study.
Biraben A; Beaussart M; Josien E; Pestre M; Savet JF; Schaff JL; Tourniaire D; Sevestre M; Renault-Djouadi J
Epileptic Disord; 2001 Jun; 3(2):91-100. PubMed ID: 11431171
[TBL] [Abstract][Full Text] [Related]
2. A randomised open-label study of tiagabine given two or three times daily in refractory epilepsy.
Arroyo S; Boothman BR; Brodie MJ; Duncan JS; Duncan R; Nieto M; Calandre EP; Forcadas I; Crawford PM
Seizure; 2005 Mar; 14(2):81-4. PubMed ID: 15694559
[TBL] [Abstract][Full Text] [Related]
3. GABI-balance--a non-interventional observational study on the effectiveness of tiagabine in add-on therapy in partial epilepsy.
Chmielewska B; Stelmasiak Z
Neurol Neurochir Pol; 2008; 42(4):303-11. PubMed ID: 18975234
[TBL] [Abstract][Full Text] [Related]
4. A double-blind, placebo-controlled trial of tiagabine given three-times daily as add-on therapy for refractory partial seizures. Northern European Tiagabine Study Group.
Kälviäinen R; Brodie MJ; Duncan J; Chadwick D; Edwards D; Lyby K
Epilepsy Res; 1998 Mar; 30(1):31-40. PubMed ID: 9551842
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of levetiracetam 1000-3000 mg/day in patients with refractory partial-onset seizures: a multicenter, open-label single-arm study.
Beran RG; Berkovic SF; Black AB; Danta G; Hiersemenzel R; Schapel GJ; Vajda FJ
Epilepsy Res; 2005 Jan; 63(1):1-9. PubMed ID: 15716083
[TBL] [Abstract][Full Text] [Related]
6. Pregabalin as adjunctive therapy for partial seizures.
Brodie MJ
Epilepsia; 2004; 45 Suppl 6():19-27. PubMed ID: 15315512
[TBL] [Abstract][Full Text] [Related]
7. Pregabalin add-on treatment in patients with partial seizures: a novel evaluation of flexible-dose and fixed-dose treatment in a double-blind, placebo-controlled study.
Elger CE; Brodie MJ; Anhut H; Lee CM; Barrett JA
Epilepsia; 2005 Dec; 46(12):1926-36. PubMed ID: 16393158
[TBL] [Abstract][Full Text] [Related]
8. Dose-dependent safety and efficacy of zonisamide: a randomized, double-blind, placebo-controlled study in patients with refractory partial seizures.
Brodie MJ; Duncan R; Vespignani H; Solyom A; Bitenskyy V; Lucas C
Epilepsia; 2005 Jan; 46(1):31-41. PubMed ID: 15660766
[TBL] [Abstract][Full Text] [Related]
9. Tiagabine: efficacy and safety in adjunctive treatment of partial seizures.
Crawford P; Meinardi H; Brown S; Rentmeester TW; Pedersen B; Pedersen PC; Lassen LC
Epilepsia; 2001 Apr; 42(4):531-8. PubMed ID: 11440349
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of two pregabalin regimens for add-on treatment of partial epilepsy.
Beydoun A; Uthman BM; Kugler AR; Greiner MJ; Knapp LE; Garofalo EA;
Neurology; 2005 Feb; 64(3):475-80. PubMed ID: 15699378
[TBL] [Abstract][Full Text] [Related]
11. Tiagabine as add-on therapy may be more effective with valproic acid--open label, multicentre study of patients with focal epilepsy.
Jedrzejczak J
Eur J Neurol; 2005 Mar; 12(3):176-80. PubMed ID: 15693805
[TBL] [Abstract][Full Text] [Related]
12. Review of controlled trials of gabitril (tiagabine): a clinician's viewpoint.
Loiseau P
Epilepsia; 1999; 40 Suppl 9():S14-9. PubMed ID: 10612357
[TBL] [Abstract][Full Text] [Related]
13. Tolerability of tiagabine: a prospective open-label study.
Bauer J; Bergmann A; Reuber M; Stodieck SR; Genton P
Epileptic Disord; 2002 Dec; 4(4):257-60. PubMed ID: 12600812
[TBL] [Abstract][Full Text] [Related]
14. Long-term effects of tiagabine monotherapy on cognition and mood in adult patients with chronic partial epilepsy.
Aikiä M; Jutila L; Salmenperä T; Mervaala E; Kälviäinen R
Epilepsy Behav; 2006 Jun; 8(4):750-5. PubMed ID: 16647884
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the cognitive effects of tiagabine and carbamazepine as monotherapy in newly diagnosed adult patients with partial epilepsy: pooled analysis of two long-term, randomized, follow-up studies.
Aikiä M; Jutila L; Salmenperä T; Mervaala E; Kälviäinen R
Epilepsia; 2006 Jul; 47(7):1121-7. PubMed ID: 16886974
[TBL] [Abstract][Full Text] [Related]
16. Tiagabine therapy for complex partial seizures. A dose-frequency study. The Tiagabine Study Group.
Sachdeo RC; Leroy RF; Krauss GL; Drake ME; Green PM; Leppik IE; Shu VS; Ringham GL; Sommerville KW
Arch Neurol; 1997 May; 54(5):595-601. PubMed ID: 9152116
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of adjunctive therapy with tiagabine in mentally disabled patients with epilepsy.
Chmielewska B; Stelmasiak Z
Ann Univ Mariae Curie Sklodowska Med; 2002; 57(1):226-36. PubMed ID: 12898928
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of adjunctive perampanel in patients with refractory partial-onset seizures: results of randomized global phase III study 305.
French JA; Krauss GL; Steinhoff BJ; Squillacote D; Yang H; Kumar D; Laurenza A
Epilepsia; 2013 Jan; 54(1):117-25. PubMed ID: 22905857
[TBL] [Abstract][Full Text] [Related]
19. The SKATE study: an open-label community-based study of levetiracetam as add-on therapy for adults with uncontrolled partial epilepsy.
Steinhoff BJ; Somerville ER; Van Paesschen W; Ryvlin P; Schelstraete I
Epilepsy Res; 2007 Aug; 76(1):6-14. PubMed ID: 17681453
[TBL] [Abstract][Full Text] [Related]
20. Tiagabine (gabitril) experience in children.
Pellock JM
Epilepsia; 2001; 42 Suppl 3():49-51. PubMed ID: 11520324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]